iMeds.se

Lopacut

Document: Lopacut film-coated tablet ENG PL change

Package leaflet: Information for the user


Lopacut 2 mg film-coated tablets

loperamide hydrochloride



Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse has told you.



What is in this leaflet

1. What Lopacut is and what it is used for

2. What you need to know before you take Lopacut

3. How to take Lopacut

4. Possible side effects

5. How to store Lopacut

6. Contents of the pack and other information


What Lopacut is and what it is used for


Lopacut contains loperamide hydrochloride. It belongs to the group of medicines known as antidiarrhoeals.


Lopacut is used:

to relieve the symptoms of sudden, short-term diarrhoea (acute diarrhoea) in adults and adolescents over 12 years.


Lopacut works by making the stools (motions) more solid and less frequent.

Doctor may prescribe this medicine for other purposes too.

You must talk to a doctor if you do not feel better or if you feel worse after 2 days.


What you need to know before you take Lopacut


Do not take Lopacut


Warnings and precautions


Children

Lopacut is not intended for children under age of 12 years.


Other medicines and Lopacut

Tell your doctor or pharmacist if you are taking, have recently taken any or might take any other medicines.


Certain drugs may affect the Lopacut treatment or Lopacut can affect certain drugs, if used simultaneously. Examples of such medicinal agents are:



Consult a doctor before using Lopacut if you use any of the above mentioned medicine.


Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine


There is no sufficient data about the use of loperamide during pregnancy, therefore you should consult your doctor before using Lopacut if you are pregnant.


Loperamide passes into the breast-milk, therefore it is not recommended to be used during breast-feeding. Consult your doctor before using Lopacut during breast-feeding.


Driving and using machines

Tiredness, dizziness and drowsiness may occur during treatment with Lopacut.


You are responsible for assessing whether you are in fit condition to drive or perform tasks that demand increased attention. One of the factors that may affect your ability to do these is the effects and/or side effects of used drugs. Description of these effects and side effects can be found in other sections. Read all the information in this leaflet for guidance. If you experience effects affecting your attention, you should not drive or use any machines.

Discuss with your doctor or pharmacist if you are unsure.


How to take Lopacut


Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.


Use in adults and adolescents over 12 years of age

2 tablets initially, followed by 1 tablet after every loose stool, not earlier than 2-3 hours after the initial dose. The maximum daily dose should not exceed 6 tablets for adults (12 mg maximum daily dose) and 4 tablets for adolescents (8 mg maximum daily dose). You should not use Lopacut longer than 2 days without consultation of a doctor.


If you take more Lopacut than you should

If you have taken more Lopacut than you should, or if children have been taking medicine by accident, please contact your doctor or the hospital to get an opinion of the risk and advice on action to be taken.


If you forget to take Lopacut

Do not take a double dose to make up for a forgotten dose.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicinecan cause side effects, although not everybody gets them.


Stop using Lopacut and tell your doctor immediatelyif you experience the following symptoms:


The following review covers side effects reported to date in terms of their frequency.


Common (may affect up to 1 in 10 people)


Uncommon (may affect up to 1 in 100 people)


Rare (may affect up to 1 in 1,000 people)


Not known (frequency cannot be estimated from the available data)

drowsiness


Reporting of side effects

If you get any side effects, talk to your doctor,pharmacistor nurse.This includes any possible side effects not listed in this leaflet.You can also report side effects directly via the national reporting system listed in Appendix V*. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Lopacut


Keep this medicine out of the sight and reach of children.

This medicinal product does not require any special storage conditions.


Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.

Do not use this medicine if you notice the tablets are damaged or don’t look right in some other way.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


What Lopacutcontains

The active substance is loperamide hydrochloride, 2 mg in one tablet.


The other ingredients are:

Tablet core: microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, colloidal anhydrous silica and magnesium stearate.


Tablet coating: polydextrose, hypromellose, titanium dioxide (E 171) and macrogol.

What Lopacutlooks like and contents of the pack

Appearance:

Tablets are white, round and convex with logo “6”. Diameter is 8 mm.


Pack sizes:

8 and 10 film-coated tablets in blister (PVC/Al).


Marketing Authorisation Holder and Manufacturer

Vitabalans Oy

Varastokatu 8

FI-13500 Hämeenlinna

FINLAND

Tel: +358 (3) 615600

Fax: +358 (3) 6183130


This medicinal product is authorised in the Member States of the EEA under the following names:

Lopacut (CZ, DE, DK, EE, FI, HU, LT, LV, NO, PL, SE, SI, SK)


This leaflet was last revised in 2015-10-22